COST EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE OVER TRIVALENT VACCINE IN FRANCE

被引：4
|
作者：
Duru, G. [1 ]
Carrat, F. [2 ]
Pribil, C. [3 ]
Bricaire, F. [4 ]
Pujol, P. [3 ]
Robert, J. [5 ]
Lafuma, A. [5 ]
机构：
[1] Cyklad Grp, Rillieux La Pape, France
[2] Univ Paris 06, Paris, France
[3] GSK, Marly Le Roi, France
[4] Hosp La Pitie Salpetriere, Paris, France
[5] Cemka Eval, Bourg La Reine, France
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2525
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN84
引用
收藏
页码：A678 / A678
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France
    Paccalin, Marc
    Gavazzi, Gaetan
    Berkovitch, Quentin
    Leleu, Henri
    Moreau, Romain
    Ciglia, Emanuele
    Burlet, Nansa
    Mould-Quevedo, Joaquin F.
    [J]. VACCINES, 2024, 12 (06)
  • [2] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    You, Joyce H. S.
    Ming, Wai-kit
    Chan, Paul K. S.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [3] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    Joyce HS You
    Wai-kit Ming
    Paul KS Chan
    [J]. BMC Infectious Diseases, 14
  • [4] Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
    de Boer, Pieter T.
    Crepey, Pascal
    Pitman, Richard J.
    Macabeo, Berengere
    Chit, Ayman
    Postma, Maarten J.
    [J]. VALUE IN HEALTH, 2016, 19 (08) : 964 - 975
  • [5] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINE IN THE UNITED STATES
    De Boer, P. T.
    Pitman, R. J.
    Macabeo, B.
    Chit, A.
    Postma, M. J.
    Crepey, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A679 - A679
  • [6] Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China
    Jiang, Minghuan
    Li, Pengchao
    Wang, Weihua
    Zhao, Mingyue
    Atif, Naveel
    Zhu, Shan
    Fang, Yu
    [J]. VACCINE, 2020, 38 (05) : 1057 - 1064
  • [7] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND
    Gibbons, I
    Davidson, C.
    Clark-Wright, J.
    Miller, C.
    Carroll, S.
    Costa, M.
    Bricout, H.
    Alvarez, F. P.
    [J]. VALUE IN HEALTH, 2020, 23 : S554 - S554
  • [8] COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM A TRIVALENT TO A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN COLOMBIA
    Castro, R.
    Rueda, J. A.
    Drzewiecka, A.
    Gorecki, M.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
  • [9] Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
    Uruena, Analia
    Micone, Paula
    Magneres, Cecilia
    Mould-Quevedo, Joaquin
    Giglio, Norberto
    [J]. VACCINES, 2021, 9 (04)
  • [10] Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey
    Amiche, Amine
    Tanriover, Mine Durusu
    Bellier, Lucile
    Ugur, Baris
    Akin, Levent
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2021, 25 : 15 - 22
12345